These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

3915 related articles for article (PubMed ID: 309867)

  • 1. Human tumor-lymphocyte interaction in vitro. III. T lymphocytes in autologous tumor stimulation (ATS).
    Vánky F; Klein E; Stjernswärd J; Rodriguez L; Péterffy A; Steiner L; Nilsonne U
    Int J Cancer; 1978 Dec; 22(6):679-86. PubMed ID: 309867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specificity of auto-tumor cytotoxicity exerted by fresh, activated and propagated human T lymphocytes.
    Vánky F; Klein E
    Int J Cancer; 1982 May; 29(5):547-53. PubMed ID: 6178704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lysis of fresh human tumor cells by autologous large granular lymphocytes and T-lymphocytes: two distinct killing activities induced by coculture with autologous tumor.
    Uchida A; Moore M
    J Natl Cancer Inst; 1984 Dec; 73(6):1285-92. PubMed ID: 6239944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DR antigens expressed on tumor cells do not contribute to the blastogenetic response of autologous T cells.
    Vánky F; Klein E; Willems J
    Cancer Immunol Immunother; 1985; 19(3):219-25. PubMed ID: 3873987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autologous mixed lymphocyte-tumor reaction and autologous mixed lymphocyte reaction. II. Generation of specific and non-specific killer T cells capable of lysing autologous tumor.
    Uchida A; Moore M; Klein E
    Int J Cancer; 1988 May; 41(5):651-6. PubMed ID: 2966771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of T-cell response in autologous mixed lymphocyte-tumor culture by large granular lymphocytes.
    Uchida A; Klein E
    J Natl Cancer Inst; 1986 Mar; 76(3):389-98. PubMed ID: 2419621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphocyte stimulation by autologous tumor cells in the presence of serum from the same patient or from healthy donors.
    Vánky F; Klein E; Stjernswärd J; Trempe G
    Int J Cancer; 1975 Nov; 16(5):850-60. PubMed ID: 1058840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autologous rosette-forming T cells as the responding cells in human autologous mixed-lymphocyte reaction.
    Palacios R; Llorente L; Alarcón-Segovia D; Ruíz-Arguelles A; Díaz-Jouanen E
    J Clin Invest; 1980 Jun; 65(6):1527-30. PubMed ID: 6447710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient generation of autologous peripheral blood-derived cytotoxic T lymphocytes against poorly immunogenic human tumors using recombinant CD80-adenovirus together with interleukin 12 and interleukin 2.
    Mogi S; Ebata T; Setoguchi Y; Fujime M; Heike Y; Kohsaka T; Yagita H; Okumura K; Azuma M
    Clin Cancer Res; 1998 Mar; 4(3):713-20. PubMed ID: 9533541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between lymphocyte-mediated auto-tumor reactivities and the clinical course. II. Evaluation of 69 patients with lung carcinoma.
    Vánky F; Péterffy A; Böök K; Willems J; Klein E; Klein G
    Cancer Immunol Immunother; 1983; 16(1):17-22. PubMed ID: 6605800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphocyte blastogenic responses to cultured allogeneic tumor cells in vitro.
    Anderson RJ; McBride CM; Hersh EM
    Cancer Res; 1972 May; 32(5):988-92. PubMed ID: 4336032
    [No Abstract]   [Full Text] [Related]  

  • 12. Depression of T lymphocyte response by non-T suppressor cells in lung cancer patients: a possible prognostic value of suppressor-cell activity.
    Han T; Takita H
    Cancer; 1979 Dec; 44(6):2090-8. PubMed ID: 228835
    [No Abstract]   [Full Text] [Related]  

  • 13. Search for anti-tumor response in a bone tumor patient with a long clinical history.
    Vanky F; Klein E; Cornain S; Bakács T; Stjernswärd J; Nilsonne U
    Int J Cancer; 1976 Sep; 18(3):282-92. PubMed ID: 1066320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Determination of active T lymphocytes in the peripheral blood by the AE rosette test. Correlation of the AE and E rosette tests with lymphocyte reactivity in vitro after PHA stimulation].
    Karwowska W; Kunicka A
    Probl Med Wieku Rozwoj; 1982; 11():111-6. PubMed ID: 6983690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-specific T-cell clones recognize different protein determinants of autologous human malignant melanoma cells.
    Notter M; Schirrmacher V
    Int J Cancer; 1990 May; 45(5):834-41. PubMed ID: 2159436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of tumor-induced lymphocyte blastogenesis by a factor or factors associated with peripheral leukocytes.
    Hattler BG; Soehnlen B
    Science; 1974 Jun; 184(4144):1374-5. PubMed ID: 4275320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lysis of autologous tumor cells by blood lymphocytes tested at the time of surgery. Correlation with the postsurgical clinical course.
    Vánky F; Klein E; Willems J; Böök K; Ivert T; Péterffy A; Nilsonne U; Kreicbergs A; Aparisi T
    Cancer Immunol Immunother; 1986; 21(1):69-76. PubMed ID: 3455878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphocyte subpopulations infiltrating squamous carcinomas of the head and neck: correlations with extent of tumor and prognosis.
    Wolf GT; Hudson JL; Peterson KA; Miller HL; McClatchey KD
    Otolaryngol Head Neck Surg; 1986 Sep; 95(2):142-52. PubMed ID: 2954014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autologous mixed lymphocyte-tumor reaction and autologous mixed lymphocyte reaction. I. Proliferation of two distinct T-cell subsets.
    Uchida A; Moore M; Klein E
    Int J Cancer; 1987 Aug; 40(2):165-70. PubMed ID: 2956198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of the growth of Epstein-Barr virus-infected B cells. I. Growth regression by E rosetting cells from VCA-positive donors is a combined effect of autologous mixed leukocyte reaction and activation of T8+ memory cells.
    Konttinen YT; Bluestein HG; Zvaifler NJ
    J Immunol; 1985 Apr; 134(4):2287-93. PubMed ID: 2857749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 196.